Mersana Therapeutics Inc (MRSN)
2.94
+0.09
(+3.16%)
USD |
NASDAQ |
Apr 26, 16:00
2.925
-0.02
(-0.51%)
After-Hours: 20:00
Mersana Therapeutics Price: 2.94 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 26, 2024 | 2.84 | 2.958 | 2.76 | 2.94 | 857407.0 |
| Apr 25, 2024 | 2.83 | 2.91 | 2.745 | 2.85 | 1.996M |
| Apr 24, 2024 | 3.21 | 3.26 | 2.80 | 2.88 | 3.535M |
| Apr 23, 2024 | 3.17 | 3.32 | 3.17 | 3.21 | 1.880M |
| Apr 22, 2024 | 3.30 | 3.30 | 3.05 | 3.15 | 1.803M |
| Apr 19, 2024 | 3.31 | 3.35 | 3.18 | 3.25 | 2.390M |
| Apr 18, 2024 | 3.44 | 3.558 | 3.315 | 3.34 | 1.274M |
| Apr 17, 2024 | 3.78 | 3.83 | 3.40 | 3.52 | 2.604M |
| Apr 16, 2024 | 3.73 | 3.805 | 3.71 | 3.76 | 683041.0 |
| Apr 15, 2024 | 3.80 | 3.96 | 3.720 | 3.79 | 1.232M |
| Apr 12, 2024 | 3.77 | 3.895 | 3.68 | 3.81 | 1.572M |
| Apr 11, 2024 | 3.74 | 3.815 | 3.68 | 3.72 | 1.427M |
| Apr 10, 2024 | 3.84 | 3.94 | 3.68 | 3.705 | 2.231M |
| Apr 09, 2024 | 4.17 | 4.18 | 3.90 | 4.10 | 1.875M |
| Apr 08, 2024 | 4.32 | 4.44 | 4.14 | 4.16 | 1.050M |
| Apr 05, 2024 | 4.23 | 4.365 | 4.09 | 4.28 | 565095.0 |
| Apr 04, 2024 | 4.52 | 4.64 | 4.25 | 4.25 | 1.279M |
| Apr 03, 2024 | 4.17 | 4.46 | 4.02 | 4.45 | 2.118M |
| Apr 02, 2024 | 4.26 | 4.33 | 4.135 | 4.22 | 1.096M |
| Apr 01, 2024 | 4.44 | 4.44 | 4.11 | 4.42 | 2.303M |
| Mar 28, 2024 | 4.52 | 4.71 | 4.47 | 4.48 | 1.398M |
| Mar 27, 2024 | 4.37 | 4.50 | 4.24 | 4.49 | 1.163M |
| Mar 26, 2024 | 4.22 | 4.48 | 4.22 | 4.30 | 1.849M |
| Mar 25, 2024 | 4.71 | 4.805 | 4.232 | 4.27 | 4.050M |
| Mar 22, 2024 | 4.85 | 4.95 | 4.68 | 4.70 | 1.164M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
1.06
Minimum
Aug 02 2023
27.59
Maximum
Dec 23 2020
8.410
Average
6.07
Median
Jan 14 2020
Price Benchmarks
| Amicus Therapeutics Inc | 10.28 |
| Geron Corp | 3.79 |
| TG Therapeutics Inc | 13.47 |
| Editas Medicine Inc | 5.32 |
| G1 Therapeutics Inc | 3.99 |
Price Related Metrics
| PS Ratio | 9.260 |
| Price to Book Value | 9.664 |
| Earnings Yield | -51.02% |
| Market Cap | 356.63M |